Assessing kidney function in HIV infection

AIDS Reader

Volumn 17, Issue 5, 2007, Pages

  Winston, Jonathan A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

HIV AIDS; Kidney disease; Kidney function estimates

Indexed keywords

CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CONCENTRATION (PARAMETERS); CREATININE BLOOD LEVEL; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; LABORATORY TEST; PATHOGENESIS; PREVALENCE; PROTEIN INTAKE; PROTEINURIA; RELIABILITY; REVIEW; URINARY EXCRETION; UROGENITAL SYSTEM;

AGED; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PREVALENCE; UNITED STATES;

EID: 34249015967     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. CDC National Center for Health Statistics. Health, United States, 2005. With Chartbook on Trends in the Health of Americans. Hyattsville, Md: US Government Printing Office; 2005. PHS 2005-1232. Available at: www.cdc.gov/nchs/hus.htm. Accessed April 4, 2007.
2. US Renal Data System, USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, Md: NIH, National Institute of Diabetes and Digestive and Kidney Diseases; 2005. Available at: www.usrds.org/adr_2005.htm. Accessed April 4, 2007.
3. National Kidney Foundation. About KEEP. Available at: http://www.kidney.org/news/keep/ KEEPabout.cfm. Accessed April 4, 2007.
4. National Kidney Disease Education Program. Kidney disease: are you at risk? Available at: http:// www.nkdep.nih.gov/. Accessed April 4, 2007.
5. Sax PE, Gallant JE, Klotman PE. Renal safety of tenofovir disoproxil fumarate. AIDS Reader. 2007; 17:90-92, 99-104, C3.
6. Kidney Disease Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):S1-S266.
7. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
8. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16: 31-41.
9. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
10. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
11. Huang E, Hewitt RG, Shelton M, Morse GD. Comparison of measured and estimated creatinine clearance in patients with advanced HIV disease. Pharmacotherapy. 1996;16:222-229.
12. Smith BL, Sarnoski TP, Dennis S, Luke DR. Failure of predicted creatinine clearance equations in HIV-seropositive patients. Int J Clin Pharmacol Ther Toxicol. 1992;30:394-399.
13. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993;329:1456-1462.
14. Brenner BM, Cooper ME, de Zeeuw D, et al; RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001; 345:861-869.
15. Szczech LA, Hoover DR, Feldman JG, et al. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis. 2004;39: 1199-1206.
16. Gardner LI, Holmberg SD, Williamson JM, et al; HIV Epidemiology Research Group. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr. 2003;32:203-209.
17. Gupta SK, Mamlin BW, Johnson CS, et al. Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients. Clin Nephrol. 2004;61:1-6.
18. Winston JA et al. Chronic kidney disease in HIV infection. J Am Soc Nephrol. 2005;16:560A.
19. Jung O, Bickel M, Dining T, et al. Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrity. Nephrol Dial Transplant. 2004;19:2250-2258.
20. Balow JE. Nephropathy in the context of HIV infection. Kidney Int. 2005;67:1632-1633.
21. Lucas GM, Eustace JA, Sozio S, et al. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS. 2004;18:541-546.
22. Klotman PE. HIV-associated nephropathy. Kidney Int. 1999;56:1161-1176.
23. Cosgrove CJ, Abu-Alfa AK, Perazella MA. Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy. Am J Med Sci. 2002;23:102-106.
24. Estrella M, Fine DM, Gallant JE, et al. HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients. Clin Infect Dis. 2006;43:377-380.
25. Atta MG, Choi MJ, Longnecker JC, et al. Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy. Am J Med. 2005;118:1288.
26. Cheng JT, Anderson HL Jr, Markowitz GS, et al. Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol. 1999;10:1566-1574.
27. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40:1559-1585.
28. Chobanian AV, Bakris GK, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [published correction appears in JAMA. 2003;290:197]. JAMA. 2003;289:2560-1572.